Brief: Kancera Q4 Operating Result SEK 9.9 Mln
Feb 21 (Reuters) - Kancera AB KANC.ST :
* Q4 OPERATING RESULT FOR QUARTER -9.9 MSEK
* Q4 RESEARCH AND DEVELOPMENT COSTS AMOUNTED TO 8.5 MSEK
Source text: ID:nMFNH6nN4
Further company coverage: KANC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing